ABHD17C
Alpha/beta hydrolase domain-containing protein 17C
Also known as: AB17C_HUMAN, FAM108C1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PCB6
- Gene
- ABHD17C
- Ensembl
- ENSG00000136379
- Chromosome
- 15
- Canonical length
- 329 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
Enables palmitoyl-(protein) hydrolase activity. Involved in protein depalmitoylation. Predicted to be located in dendritic spine; postsynaptic density membrane; and recycling endosome membrane. Predicted to be active in endosome membrane; glutamatergic synapse; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
329 residues, UniProt reviewed canonical sequence.
>Q6PCB6|ABHD17C
1 MPEPGPRMNG FSLGELCWLF CCPPCPSRIA AKLAFLPPEP TYTVLAPEQR GAGASAPAPA
61 QATAAAAAAQ PAPQQPEEGA GAGPGACSLH LSERADWQYS QRELDAVEVF FSRTARDNRL
121 GCMFVRCAPS SRYTLLFSHG NAVDLGQMCS FYIGLGSRIN CNIFSYDYSG YGVSSGKPSE
181 KNLYADIDAA WQALRTRYGV SPENIILYGQ SIGTVPTVDL ASRYECAAVI LHSPLMSGLR
241 VAFPDTRKTY CFDAFPSIDK ISKVTSPVLV IHGTEDEVID FSHGLAMYER CPRAVEPLWV
301 EGAGHNDIEL YAQYLERLKQ FISHELPNSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABHD17C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 61 nTPM
Expression across tissuesHPA
Tissue
- colon: 61 nTPM
- rectum: 53 nTPM
- esophagus: 45 nTPM
- stomach: 34 nTPM
- small intestine: 29 nTPM
- urinary bladder: 27 nTPM
Single-cell type
- esophageal apical cells: 338 nCPM
- foveolar cells: 245 nCPM
- colonocytes: 235 nCPM
- goblet cells: 223 nCPM
- respiratory basal cells: 192 nCPM
- ocular epithelial cells: 156 nCPM
Immune cell
- gdT-cell: 0.7 nTPM
- memory CD8 T-cell: 0.7 nTPM
- MAIT T-cell: 0.5 nTPM
- memory CD4 T-cell: 0.5 nTPM
- memory B-cell: 0.3 nTPM
- plasmacytoid DC: 0.3 nTPM
Brain region
- hippocampal formation: 22 nTPM
- hypothalamus: 20 nTPM
- basal ganglia: 19 nTPM
- amygdala: 19 nTPM
- cerebral cortex: 19 nTPM
- spinal cord: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 3.14
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of protein localization to microtubule
- positive regulation of protein localization to endosome
- protein depalmitoylation
- regulation of postsynapse organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABHD17C as an antibody target. Whether an autoantibody or antibody against ABHD17C could matter depends on whether native ABHD17C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABHD17C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ABHD17C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...